Search

Your search keyword '"McKenna-Yasek, Diane"' showing total 216 results

Search Constraints

Start Over You searched for: Author "McKenna-Yasek, Diane" Remove constraint Author: "McKenna-Yasek, Diane"
216 results on '"McKenna-Yasek, Diane"'

Search Results

1. Author Correction: The SOD1-mediated ALS phenotype shows a decoupling between age of symptom onset and disease duration

2. Pathogenic Huntingtin Repeat Expansions in Patients with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis

4. The SOD1-mediated ALS phenotype shows a decoupling between age of symptom onset and disease duration

5. AAV gene therapy for Tay-Sachs disease

6. Suppression of mutant C9orf72 expression by a potent mixed backbone antisense oligonucleotide

7. Correction to: The SOD1-mediated ALS phenotype shows a decoupling between age of symptom onset and disease duration (Nature Communications, (2022), 13, 1, (6901), 10.1038/s41467-022-34620-y)

8. Genome-wide Analyses Identify KIF5A as a Novel ALS Gene

10. Prospective natural history study of C9orf72 ALS clinical characteristics and biomarkers

12. Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways

14. The SOD1-mediated ALS phenotype shows a decoupling between age of symptom onset and disease duration

15. Reduced Expression of the Kinesin-Associated Protein 3 (KIFAP3) Gene Increases Survival in Sporadic Amyotrophic Lateral Sclerosis

16. Suppression of mutant C9orf72 expression by a potent mixed backbone antisense oligonucleotide

17. ALS GENES: Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways

19. Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis

20. Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosis

21. Deleterious variants of FIG4, a phosphoinositide phosphatase, in patients with ALS

22. First-in-human AAV Gene Therapy for Tay-Sachs Disease

23. Potent Mixed Backbone Antisense Oligonucleotide Safety Suppressed Expression of Mutant C9ORF72 Transcripts and Polypeptides: First in Human Pilot Study

26. SOD1Suppression with Adeno-Associated Virus and MicroRNA in Familial ALS

27. A Safe and Reliable Technique for CNS Delivery of AAV Vectors in the Cisterna Magna

32. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis

34. Linkage of a gene causing familial amyotrophic lateral sclerosis to chromosome 21 and evidence of genetic-locus heterogeneity

36. Correction of pseudoexon splicing caused by a novel intronic dysferlin mutation

37. Genome-wide Analyses Identify KIF5A as a Novel ALS Gene

38. Genome-wide Analyses Identify KIF5A as a Novel ALS Gene

39. Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis

41. Genome-Wide Analyses Identify KIF5A as a Novel ALS Gene

43. NEK1 variants confer susceptibility to amyotrophic lateral sclerosis

44. Suppression of mutant C9orf72expression by a potent mixed backbone antisense oligonucleotide

45. A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DELAYED-START TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF L-SERINE IN SUBJECTS WITH HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 1 (HSAN1) (S45.001)

46. NEK1 variants confer susceptibility to amyotrophic lateral sclerosis

47. Deleterious Variants of FIG4, a Phosphoinositide Phosphatase, in Patients with ALS

Catalog

Books, media, physical & digital resources